A股異動丨華寶股份(300741.SZ)大漲近8% 多家機構唱多
格隆匯9月22日丨華寶股份(300741.SZ)低開高走,現大漲近8%,報55.28元,總市值340.5億元。天風證券研報稱,公司作為國內煙用香精龍頭,技術與規模優勢顯著,產品壁壘高。今年二季度銷售毛利率為75.87%,同比降低1.32%;銷售淨利率為57.58%,同比上升4.99%,整體來看公司盈利能力仍然保持在較高水平。國泰君安亦發佈研報稱,華寶股份業績穩定性強,研發與客户優勢顯著,三大業務板塊成長路徑清晰,維持2020-2022年EPS2.08、2.22、2.42元,考慮後續新業務發力,給予2021年30XPE,上調目標價至66.5元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.